Acadia Healthcare (NASDAQ:ACHC) Hits New 12-Month High – What’s Next?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $34.90 and last traded at $34.43, with a volume of 1615129 shares changing hands. The stock had previously closed at $34.50.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on ACHC. Cantor Fitzgerald raised their price objective on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Guggenheim boosted their target price on shares of Acadia Healthcare from $26.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, May 4th. KeyCorp increased their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Royal Bank Of Canada lifted their price target on shares of Acadia Healthcare from $28.00 to $31.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Finally, TD Cowen upped their price target on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average price target of $28.69.

Acadia Healthcare Stock Down 2.3%

The company has a market cap of $3.20 billion, a price-to-earnings ratio of -2.84, a P/E/G ratio of 11.88 and a beta of 0.64. The company has a current ratio of 1.71, a quick ratio of 1.71 and a debt-to-equity ratio of 1.27. The business has a fifty day moving average price of $27.32 and a two-hundred day moving average price of $22.96.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same period last year, the company posted $0.40 earnings per share. The firm’s quarterly revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, equities analysts predict that Acadia Healthcare Company, Inc. will post 1.5 earnings per share for the current year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors have recently modified their holdings of ACHC. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of Acadia Healthcare during the first quarter worth $1,600,000. Goldman Sachs Group Inc. boosted its position in Acadia Healthcare by 21.1% during the first quarter. Goldman Sachs Group Inc. now owns 698,225 shares of the company’s stock valued at $21,170,000 after purchasing an additional 121,444 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Acadia Healthcare by 8.7% in the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 340,916 shares of the company’s stock valued at $10,337,000 after purchasing an additional 27,207 shares in the last quarter. American Century Companies Inc. increased its position in Acadia Healthcare by 531.5% in the 2nd quarter. American Century Companies Inc. now owns 105,739 shares of the company’s stock worth $2,399,000 after purchasing an additional 88,995 shares during the last quarter. Finally, Prudential Financial Inc. increased its position in Acadia Healthcare by 21.9% in the 2nd quarter. Prudential Financial Inc. now owns 9,903 shares of the company’s stock worth $225,000 after purchasing an additional 1,780 shares during the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.